Biovie BIVI
NASDAQ BIVI
$1.95 +0.09 (+4.84%)
At close: Aug 21, 2026 · 4:00 PM EDT

Biovie (BIVI) Change in Account Payables (2013 - 2026)

Biovie (BIVI) posted Change in Account Payables of -$1.3 million for Q1 2026, down 196.69% sequentially from $1.4 million in Q4 2025, and down 220.0% YoY from $1.1 million in Q1 2025.

Biovie (BIVI) Change in Account Payables (2013 - 2026) Analysis & Trends

Biovie has reported Change in Account Payables for 14 years, with the latest figure at -$1.3 million in Q1 2026.

  • Quarterly Change in Account Payables fell 220.0% year-over-year to -$1.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$864528.0 (up 55.3% YoY) and the FY2025 annual result came in at -$1.4 million, down 1353.1% from the prior year.
  • Change in Account Payables declined to -$1.3 million in Q1 2026 per BIVI's latest filing, from $1.4 million in the prior quarter.
  • Over five years, Change in Account Payables peaked at $1.6 million in Q1 2023 and troughed at -$2.1 million in Q4 2024.
  • A 5-year average of -$1256.4 and a median of -$133940.0 in 2024 frame the typical range for Change in Account Payables.
  • The widest YoY moves for Change in Account Payables: up 448.93% in 2023, down 462.71% in 2023.
  • Over 5 years, Change in Account Payables stood at $623080.0 in 2022, then soared by 43.37% to $893336.0 in 2023, then sank by 331.77% to -$2.1 million in 2024, then jumped by 165.54% to $1.4 million in 2025, then tumbled by 196.69% to -$1.3 million in 2026.
  • According to Business Quant data, Change in Account Payables over the past three periods registered -$1.3 million, $1.4 million, and -$633956.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Account Payables (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn -66.70 Mn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn -
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -8.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 37.53 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn -
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn -
9 Royalty Pharma 27.27 Bn 26.43 Bn - -
10 Biovie 14.17 Mn 14.17 Mn - 2.09 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 2.09 Mn
Jun 30, 2026 2.09 Mn
Mar 31, 2026 -1.31 Mn
Mar 31, 2026 -1.31 Mn
Dec 31, 2025 1.36 Mn
Dec 31, 2025 1.36 Mn
Sep 30, 2025 -633,956.00
Sep 30, 2025 -633,956.00
Jun 30, 2025 -275,520.00
Jun 30, 2025 -275,520.00
Mar 31, 2025 1.09 Mn
Mar 31, 2025 1.09 Mn
Dec 31, 2024 -2.07 Mn
Dec 31, 2024 -2.07 Mn
Sep 30, 2024 -133,940.00
Sep 30, 2024 -133,940.00
Jun 30, 2024 -822,842.00
Jun 30, 2024 -822,842.00
Mar 31, 2024 801,658.00
Mar 31, 2024 801,658.00